ChemScene, a subsidiary of Shanghai Haoyuan Chemexpress Co., Ltd., is a leading global CRDMO founded in 2011. We specialize in the supply of innovative Building Blocks, Intermediates, APIs, Bioactive Small Molecules, Screening Libraries, FTE, Bulk Production, Custom Synthesis Services, process optimization and commercial production for peptide, oligonucleotide, and ADC drug to support medicinal chemistry and drug development worldwide. ChemScene’s offerings also include ADC Linkers, PROTACs, Catalysts, Ligands, materials science products, synthetic reagents, and more. ChemScene offers a vast catalog of over 70,000 compounds, with over 40,000 available in US stock. Notably, 26% of our catalog is self-developed and exclusive to ChemScene. Our R&D team, comprising over 2,100 chemists, more than half of whom hold advanced degrees, collaborates closely with pharmaceutical and biotech companies, universities, and research institutes. Our products are rigorously tested to ensure quality and purity levels necessary for drug development. Products are available in variable quantities and are shipped the same day as receipt of purchase order to meet customer needs.